Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02107300 · ClinicalTrials.gov registry record · NA
NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02107300 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 32 participants.
The verdict
NCT02107300, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
To assess whether the daily use of NeutraSal will prevent or reduce dry mouth in patients undergoing CPAP therapy for OSAS and improve CPAP compliance
Interventions
- DRUG Placebo Comparator
- DRUG NeutraSal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2013-11 |
| Est. Completion | 2017-07-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02107300
The ClinicalTrials.gov registry entry for NCT02107300 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Comparator is the first listed.
NCT02107300 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02107300 about?
NCT02107300 is a clinical study titled "NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy". To assess whether the daily use of NeutraSal will prevent or reduce dry mouth in patients undergoing CPAP therapy for OSAS and improve CPAP compliance
What is the current status of trial NCT02107300?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2013-11. Estimated completion is 2017-07-03.
What interventions are being tested in trial NCT02107300?
The interventions under investigation include: Placebo Comparator (DRUG), NeutraSal (DRUG).
Who is sponsoring clinical trial NCT02107300?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.